Technology News and Research

RSS

New Bruker-Biognosys collaboration aims to deliver advanced proteomics CRO services

Bruker Corporation and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan acted as exclusive financial advisor to Biognosys.

From Bruker BioSpin Group 10 Jan 2023

Understanding cat locomotion could help develop better treatment for human spinal cord injury

Cats always land on their feet, but what makes them so agile? Their unique sense of balance has more in common with humans than it may appear.

9 Jan 2023

Research explores whether the eye influenced the development of language

Eyes provide us with most information about the surrounding world. Yet, the eye, especially that of a human, enables not only to receive stimuli but also to transfer this information outside.

9 Jan 2023

New smart soft contact lenses can monitor intraocular pressure for 24-hour cycles to detect glaucoma

Optometrists, ophthalmologists and their patients will benefit from new, high-tech tools to detect glaucoma at its earliest stages thanks to a startup that will commercialize smart contact lenses developed at Purdue University.

9 Jan 2023

Detailed molecular profile of endometriosis can lead to improved care for millions of women

Investigators at Cedars-Sinai have created a unique and detailed molecular profile of endometriosis to help improve therapeutic options for the millions of women suffering from the disease.

9 Jan 2023

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

Europe is experiencing an increasingly large circulation of influenza and the respiratory syncytial virus (RSV).

9 Jan 2023

UCD HealthTech spin-out raises €525,000 to launch a 12-month weight management program

Beyondbmi, a University College Dublin (UCD) HealthTech spin-out company supported by NovaUCD, has announced closing a €525,000 pre-seed funding round, advised by CKS Finance.

9 Jan 2023

Clinically relevant biomarker strategies in drug development

In this interview, NewsMedical speaks with Dr. Justin Devine and Dr. Nicholas Woudberg about biomarkers, their importance for drug development as well as the potential they have when it comes to machine learning.

From Synexa Life Sciences 9 Jan 2023

Study finds older knee replacement designs to be just as effective as newer models

Older knee replacement designs are just as effective as newer models - according to new research from the Norfolk and Norwich University Hospital and University of East Anglia.

6 Jan 2023

Pan-vaccine antigen strategy confers protection against cross-clade SARS-CoV-2 variants, including vaccine-resistant Omicron variants

Researchers developed a novel pan-vaccine antigen (Span)-based subunit vaccine against COVID-19.

6 Jan 2023

Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA)

Cerba Research announces membership of HKBMIA to act as an advisor on speciality testing and routine clinical trials testing to advance research and health while supporting Asia pacific healthcare companies develop new therapeutics.

From Cerba Research 6 Jan 2023

Study offers novel insights into the elongation dynamics of eukaryotic cells

Life depends on the precise functioning of several proteins synthesized in cells by ribosomes. This diverse set of proteins, known as a proteome, is maintained by the robust translation elongation of amino acid sequences taking place in the ribosomes.

5 Jan 2023

New electrically conductive hydrogel scaffold supports neural cell differentiation

Brain-computer interfaces (BCIs) are a hot topic these days, with companies like Neuralink racing to create devices that connect humans' brains to machines via tiny implanted electrodes.

5 Jan 2023

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Trials into vaccines for cancer and wider diseases will accelerate after the government reached a historic agreement with a leading biopharmaceutical firm to bring revolutionary research to England.

5 Jan 2023

Researchers develop a new approach to better understand the biology of polycystic kidney disease

A research team supported by the National Institutes of Health has developed a new approach to better understand the biology of polycystic kidney disease (PKD), an often-life-threatening genetic disorder that affects millions worldwide.

5 Jan 2023

FUJIFILM Europe urology solutions demonstrated at ERUS 2022

FUJIFILM Europe exhibited at the annual meeting of the European Association of Urology Robotic Urology Section (ERUS). ERUS22 took place at the Palau de Congressos de Barcelona from the 26th to the 28th of October.

From FUJIFILM Corporation 5 Jan 2023

New statistical model can be used to prevent accidents involving children

A research team led by Kojiro Matsuo, an associate professor at the Department of Architecture and Civil Engineering within the Toyohashi University of Technology, and Kosuke Miyazaki, a professor at the Department of Civil Engineering within the National Institute of Technology – Kagawa College, has established an efficient means of identifying road intersections at high potential risk of accidents involving children.

5 Jan 2023

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim, one of the world-leading pharmaceutical companies developing innovative therapies for diseases with unsatisfactory treatments.

From PhoreMost 5 Jan 2023

Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs

...

From Orbit Discovery 5 Jan 2023

Recently discovered protein holds potential for the development of new tests for infectious diseases

In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA.

4 Jan 2023

Technology News and Research

New Bruker-Biognosys collaboration aims to deliver advanced proteomics CRO services

Understanding cat locomotion could help develop better treatment for human spinal cord injury

Research explores whether the eye influenced the development of language

New smart soft contact lenses can monitor intraocular pressure for 24-hour cycles to detect glaucoma

Detailed molecular profile of endometriosis can lead to improved care for millions of women

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

UCD HealthTech spin-out raises €525,000 to launch a 12-month weight management program

Clinically relevant biomarker strategies in drug development

Study finds older knee replacement designs to be just as effective as newer models

Pan-vaccine antigen strategy confers protection against cross-clade SARS-CoV-2 variants, including vaccine-resistant Omicron variants

Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA)

Study offers novel insights into the elongation dynamics of eukaryotic cells

New electrically conductive hydrogel scaffold supports neural cell differentiation

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Researchers develop a new approach to better understand the biology of polycystic kidney disease

FUJIFILM Europe urology solutions demonstrated at ERUS 2022

New statistical model can be used to prevent accidents involving children

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs

Recently discovered protein holds potential for the development of new tests for infectious diseases

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News